Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
Relevant materials may include regulatory submissions, FDA correspondence, inspection records, Forms FDA 483, warning letters, recall documentation, product labeling, adverse-event records, guidance documents, approval or clearance materials, compliance records, and other agency files. The specific evidence depends on the FDA-regulated product and the regulatory question involved. FDA currently regulates a broad range of products, including foods, human and veterinary drugs, biologics, medical devices, cosmetics, radiation-emitting products, and tobacco products.
FDA regulations establish legally binding requirements when issued under applicable statutory authority. Guidance documents generally describe the agency’s current thinking and recommended approaches, but they do not ordinarily create independently enforceable legal obligations unless specific regulatory requirements are separately applicable. That distinction can matter in litigation because an expert should identify whether a disputed practice is tied to a statute or regulation, an agency procedure, or nonbinding guidance rather than treating all FDA materials as equivalent. FDA separately maintains its rules and regulations and its guidance-document system.
FDA inspections can examine whether regulated facilities are complying with applicable requirements and may occur as surveillance, for-cause, application-based, or follow-up inspections. Records generated from inspections or later compliance activity can help establish what the agency observed, what concerns were identified, and how a company responded. FDA’s regulatory procedures also distinguish among advisory, administrative, and judicial actions, so the meaning of a warning letter, inspectional observation, recall-related action, or enforcement matter should be evaluated in its actual procedural context.
FSMA is primarily preventive in orientation. It expanded FDA’s food-safety framework through requirements and programs involving hazard analysis and preventive controls, produce safety, imported-food verification, sanitary transportation, intentional adulteration, food traceability, and related compliance systems. The Food Traceability Rule is part of that framework, although FDA is currently directed not to enforce it before July 20, 2028. An FDA expert may examine food-safety plans, hazard analyses, preventive-control records, supplier verification documentation, inspection records, corrective actions, or other evidence when FSMA requirements are relevant. For imported food, the Foreign Supplier Verification Programs rule can require covered importers to evaluate hazards and suppliers and perform appropriate verification activities.
Analytical Chemistry, +4
Manufacturing
Food And Drug Administration (FDA), +4
Pharmaceutical
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
The central issue should control the choice. Food Safety expertise may be more appropriate when the dispute is primarily about contamination, sanitation, hazard analysis, or preventive controls. Pharmaceutical, Medical Device, or other product-specific expertise may be needed when product development, manufacturing, performance, or technical product issues dominate. Clinical Trials expertise may be more appropriate when the dispute centers on study conduct, protocol compliance, or clinical research evidence. An expert with appropriate FDA regulatory experience may be useful when agency procedures, regulatory submissions, inspections, approvals or clearances, compliance history, labeling, enforcement processes, or the context and significance of FDA records are central to the dispute. The expert's qualifications should match the particular FDA-regulated product and regulatory issue, without substituting for the legal conclusions of the applicable decision-maker.
Epidemiology, +4
Pharmaceutical
Biomedical Engineering, +4
Healthcare